Rosa Escudero-Sanchez

12PUBLICATIONS
46CO-AUTHORS
PainPredictive and prognostic markersEpidemiological modellingEpidemiological methodsCognition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 14, 2025
Intravenous Administration of Remdesivir at the Acute Phase of SARS-CoV-2 Infection Is Associated with a Lower Prevalence of Post-COVID-19 Pain.

César Fernández-de-Las-Peñas, Anabel Franco-Moreno, María Ruiz-Ruigómez

|Jun 27, 2024
Is Antiviral Treatment with Remdesivir at the Acute Phase of SARS-CoV-2 Infection Effective for Decreasing the Risk of Long-Lasting Post-COVID Symptoms?

César Fernández-de-Las-Peñas, Anabel Franco-Moreno, María Ruiz-Ruigómez

|Oct 27, 2023
Production of OXA-48 carbapenemase acts as an independent risk factor for poor outcome in Klebsiella pneumoniae infection.

Laura Corbella, Mario Fernández-Ruiz, María Ruiz-Ruigómez

|Mar 02, 2023
Conventional versus extended-pulsed fidaxomicin dosing in patients at high risk of recurrence of Clostridioides difficile infection: a propensity score analysis.

Rosa Escudero-Sánchez, Elena Rubio Martín, Pilar Vizcarra

|Aug 26, 2022
Long-Term Follow-Up of Patients Diagnosed with COVID-19-Associated Pulmonary Aspergillosis (CAPA).

María Ruiz-Ruigómez, Mario Fernández-Ruiz, Ana Pérez-Ayala

|Apr 23, 2022
Essential Topics for the Regulatory Consideration of Phages as Clinically Valuable Therapeutic Agents: A Perspective from Spain.

Roberto Vázquez, Roberto Díez-Martínez, Pilar Domingo-Calap

Pageof 2

Frequent Collaborators

5 joint publications

José María Aguado

3 joint publications

Francisco López-Medrano

3 joint publications

Mario Fernández-Ruiz

2 joint publications

Isabel Rodríguez-Goncer